Immunofluorescence quantification of γH2AX foci is a powerful approach to quantify DNA double-strand breaks induced by cancer therapy or accidental exposure to ionizing radiation. Here we report a modification to the γH2AX immunofluorescence labeling method, whereby cells are stained in-solution before being spotted and fixed onto microscope slides. Our modified method allows arraying of 16 patient samples/slide ready for foci counting in 2 h and demonstrated reliably detection of γH2AX foci in mononuclear cells prepared from patients who had undergone radiation therapy.
Cancer treatment often involves the use of DNA double-strand break (DSB)-inducing agents such as ionizing radiation (IR) or chemotherapy drugs, such as etoposide. IR dosing is challenged by the individual variation in patients normal tissue sensitivity (1, 2) . The pharmacokinetic properties of most chemotherapeutic drugs result in large interindividual variations in serum concentrations when the same dose/square meter have been delivered intravenously (3). Therefore, a major challenge is finding ways in which to individualize dosing of these toxic agents, either when used alone or in combination with IR, to optimize patient therapy. It is possible that direct measurement of the amount of DSBs induced in blood mononuclear cells could be used as a dosing guide. A key protein in DNA damage signaling and repair is the nucleosomal histone protein H2AX, which becomes rapidly phosphorylated at serine 139 (γH2AX) at the DSB site (4) . H2AX phosphorylation extends up to 1-2 megabases flanking the DSB site, allowing immunofluorescence (IF) detection of discrete nuclear γH2AX foci formed at the DSBs (5, 6) . The number of γH2AX foci closely corresponds to the number of DSBs, with each DSB probably yielding one focus making γH2AX foci counting the most sensitive technique to monitor DSBs (6, 7) . However, the method is time-consuming, mainly due to the inconvenience of staining cells on microscope slides and counting γH2AX foci in at least 50-100 cells, which is necessary for reliable DSB frequency determination. Less sensitive flow cytometry methods to detect γH2AX have been developed for clinical applications (8, 9 ). Yet, the foci method is still the only technique that allows reliable detection of the low levels of DSBs induced by conventional cancer therapy (6) .
Several microscopic systems utilizing software that allow reliable automatic counting of foci are now available, but since most microscopic systems can only process eight microscope slides/run, the capacities of these systems are still too low for clinical applications. To address these limitations, we have developed an in-solution IF staining methodology to array mononuclear cells from patient samples for foci counting in less than 2 h and verified that this method allows reliable detection of γH2AX foci in clinical samples.
Materials and methods
Preparation of mononuclear cells and treatments Mononuclear cells were prepared from blood collected in EDTA tubes by the lymphoprep procedure (Axis-Shield, Oslo, Norway) and treated with the DSB-inducing drug calicheamicin (CLM) as described previously (8, 10) . CLM interacts with doublehelical DNA in the minor groove and causes site-specific double-stranded cleavage (11) . In vitro radiation of blood was carried out with an RT-100 Superficial Therapy X-ray (Philips, DA Best, The Netherlands) with 100 kVp, 8 mA, and 1.7 mm aluminum filter as described previously (8) . The dose rate was 1.46 Gy/min, and the focus-totarget distance was 30 cm. The blood was incubated for 30 min at 37°C before preparation of lymphocytes. Blood samples were collected from two cancer patients before and 1 h after a 2 Gy radiation dose. The patients were treated in a linear accelerator with 6 and 15 MV photons. Mononuclear cells were prepared directly from blood collected from patients 1 h post-IR. Blood was kept on ice after collection during all storage and handling steps.
Patients gave their written informed consent, and the procedure was approved by the regional ethics committee of Gothenburg, Sweden.
Fibroblast cell culture, treatment, and preparation of standard controls Human fibroblasts (ATCC CRL-2091) were grown in minimum essential medium (MEM) Eagle medium (Sigma-Aldrich, Stockholm, Sweden), supplemented with 10% fetal calf serum (Sigma-Aldrich), 100 U/mL penicillin, 100 μg/mL streptomycin (Sigma-Aldrich), 1 (12) . The cells were then harvested by trypsinization and washed with ice-cold PBS.
To prepare standard controls for the staining procedure, fibroblasts were treated with CLM at serial dilutions and resuspended in a small volume of PBS. Ice-cold ethanol was added to the cells dropwise, while mixing, to a final concentration of 90%. The cells were stored in single aliquots of 10 5 cells/sample at -70°C. For each staining procedure, an aliquot from each CLM concentration was stained alongside the patient samples. Flow cytometry analyses of the γH2AX signals among control fibroblasts stored for different times at -70°C were done as described previously (8) In-solution IF labeling of γH2AX Unless otherwise indicated, all steps were carried out on ice or at 4°C. The overall steps in the staining procedure are listed in Figure 1A . Cells (50-100 × 10 3 fibroblasts or mononuclear cells) treated with DNA damaging agents were fixed in 25 μL 0.25% paraformaldehyde(PFA)-PBS for 15 min on ice before addition of 150 μL permeabilization buffer [1× PBS, 0.1% Triton X-100, 1 g/L BSA, 0.25 g/L sonicated calf thymus DNA, and phosphatase inhibitors (10 mM NaF, 1 mM Na 2 MoO 4 , 1 mM NaVO 3 ) containing the γH2AX antibody (05-636; Millipore AB, Billerica, Massachusetts) diluted 1:3000]. Cells were incubated for 15 min to 24 h with gentle inversions of the tubes. Longer staining times resulted in stronger fluorescence signals, but did not affect the number of countable foci. Cells were washed by adding 1 mL cold wash buffer (0.1 g/L BSA in PBS) and centrifuged at 10,000× g for 5 min. The supernatant was then removed, leaving behind about 20 μL. The cell pellet was resuspended in 150 μL permeabilization buffer containing a 1:1000 dilution of Alexa-fluor 488 goat anti-mouse antibody (A11017; Invitrogen) and incubated for 30 min with gentle inversion of the tube. After centrifugation and removal of the supernatant, the cells were resuspended in the spotting buffer (0.01% Triton X-100, 3 g/L BSA, distilled water), centrifuged, and the supernatant was removed, leaving 50 μL behind for resuspending the cells. Five microliters cell suspension were spotted onto a microscope slide and allowed to air-dry for 30 min creating a cell "spot." Up to 16 samples were spotted on each slide. Drying the slides under an airflow (e.g., under a low speed fan) sped up the drying step. The dried slides were fixed in an ice-cold solution of acetone-methanol (1:1) for 2 min and air-dried briefly. The slides were then incubated in a chamber with 1:1000 Hoechst 33342 dye (H3570; Invitrogen) in PBS for 3 min, washed twice by dipping the slide in and out of distilled water, dried briefly, and mounted with a cover glass using fluorescence mounting medium (Dako, Glostrup, Denmark). Notably, the Hoechst 33342 dye can be added to the secondary antibody solution, eliminating this step. Cells were then imaged with a wide-field fluorescence microscope (Zeiss Axioskop; Carl Zeiss AB, Stockholm, Sweden) or a confocal laser scanning microscope (Zeiss LSM 510 META; Carl Zeiss AB). Ethanolfixed control fibroblasts stored at -70°C were collected by centrifugation for 2 min, the supernatant was removed, and residual ethanol evaporated by incubation of the tubes without the lid on ice for 5 min, before continuing with the staining procedure described above. Foci were counted manually from 50 cells using digital images taken with a wide-field fluorescence microscope (100× objective) and processed with ImageJ software (free software provided by the National Institutes of Health).
Conventional (on-slide) staining of γH2AX foci Cells (50-100 × 10 3 fibroblasts or mononuclear cells) treated with DNA damaging agents were fixed in 50 μL PBS containing 
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0.25% PFA for 15 min on ice. The cells were then spun down, and the fix solution removed. The cells were resuspended in 50 μL spotting solution and spotted on microscope slides as described for in-solution staining. The slides were then dried and fixed in acetone-methanol (1:1) (see in-solution staining). Slides were then blocked in the BSA containing permeabilization buffer (for consistency with the previous section, see in-solution staining) without phosphatase inhibitors for 30 min in a staining chamber with rocking at room temperature. Primary antibody (see in-solution staining) was added to the permeabilization buffer at 1:3000, and the slides were incubated with rocking overnight. The slides were dipped once in distilled water and washed for 15-30 min in the permeabilization buffer in a staining chamber with rocking. The slides were dipped in distilled water once more and stained with a 1:1000 dilution of secondary antibody (see in-solution staining) in permeabilization buffer for 1 h with rocking. The slides were then dipped in distilled water, washed in permeabilization buffer for 15-30 min, and processed as described for in-solution staining.
Results and discussion
To enable arraying of cell preparations on microscope slides, we suspended PFA-fixed mononuclear cells in a spotting solution containing detergent and BSA, but no salts. After drying and fixation in methanol:acetone, cells were efficiently retained on the glass surface through fixation of the dried BSA. Since the spotting solution lacked salts that form crystals and cause osmotic damage during the drying process, the morphology of the cells was preserved. Using this spotting technique, it was simple to array 16 cell samples on a microscope slide.
Antibody staining of cell samples on microscope slides is laborious and requires relatively large volumes of staining solution. In addition, since cells are attached to a glass surface, diffusion of antibodies is restricted compared with cells stained in-solution, requiring longer incubation times to detect γH2AX foci. We found cells stained with the γH2AX antibody in-solution could be efficiently arrayed with our spotting technique without affecting the quality of the microscopic images or the foci counting. Through optimization of this in-solution IF staining and spotting protocol, γH2AX foci could be reliably detected after a 15-min antibody incubation using gentle mixing of mononuclear cells treated with the DSB-inducing drug CLM and fixed with 0.25% PFA. A work flow diagram of the in-solution γH2AX staining protocol is shown in Figure 1A .
Longer incubation times, up to 24 h, resulted in stronger fluorescence signal, but did not affect the quality of the microscopic images or foci counting ( Figure  1B) . The in-solution technique using an antibody staining time of 1 h resulted in similar γH2AX foci counts in irradiated mononuclear cells compared with overnight antibody incubation with conventional staining on microscope slides (Figure 2A ). In addition, the foci were comparable in brightness and appearance ( Figure 2B ). Numbers of foci in untreated lymphocytes were low (0.04 foci/nuclei) for both staining procedures; low γH2AX foci/nuclei in peripheral blood lymphocytes, which are noncycling and have a minimal rate of oxidative metabolism have been reported by others (13, 14) . We also examined the in-solution IF staining technique using patient samples. Blood samples were drawn from two patients before and 1 h after a 2 Gy radiation dose. As a control, a portion of the blood sample drawn before irradiation was irradiated in vitro to a dose of 2 Gy ( Figure   3A ). Patient 1 was a 44-year-old woman receiving chemoradiation for an esophageal cancer. The blood sampling was done toward the end of her radiation course and she had received chemotherapy 20 days prior to sampling. Primary tumor volume (PTV) was 223 cm 3 . Patient 2 was a 70-year-old woman receiving adjuvant radiotherapy to the right breast. Sampling was done on the first day of treatment, and PTV was 841 cm 3 . As expected, the in-solution IF staining technique revealed a subset of mononuclear cells with γH2AX foci only in the blood sample drawn 1 h after irradiation and in all mononuclear cells prepared from the in vitro irradiated blood sample ( Figure 3A) . For each patient, the number of foci in 200 cells was counted manually, and a foci distribution chart was generated as a proof of principle ( Figure 3B ). The average number of foci/nuclei in the lymphocytes prior to irradiation was 0.08 and 0.03 in patients 1 and 2, respectively (n = 100). The distribution of γH2AX foci in the two patients postradiation was very distinct, with 20% of cells in patient 1 containing more than two foci/nuclei, relative to 10% of cells in Methods used in clinical applications require control samples to monitor any changes in method performance over time, such as differences among antibody batches. We found that human primary fibroblasts, fixed in ethanol and stored for over 40 days at -70°C (control fibroblasts), did not lose their γH2AX signal, as determined by flow cytometry ( Figure 4A ). In addition, the quality of γH2AX foci as well as cell morphology in CLM-treated control fibroblasts were preserved ( Figure 4B) . Furthermore, the number of γH2AX foci/ nuclei in control fibroblasts was comparable to the fresh fibroblasts (data not shown). Notably, in fibroblasts fixed in ethanol, the cytoplasm remains intact giving rise to some background staining. However, this staining was not present in nuclei and varied significantly compared with the discrete and more intense γH2AX foci staining, making it easy to exclude the background both by eye as well as foci counting software. We conclude that the in-solution IF staining of γH2AX foci described here generates arrayed patient samples that are ready for foci counting in 2 h.
IF visualization of γH2AX foci in blood mononuclear cells is a powerful technique able to detect low levels of DSBs produced during cancer therapy or accidental radiation exposures. This technique is now under testing in several clinical situations involving individualization of chemotherapy dosing and detection of cellular damage following radiotherapy (7, (15) (16) (17) . Yet, the technique is still too labor-intensive and time-consuming to be implemented in clinical routines. Several fluorescence-microscopic systems with motorized stages accepting up to eight slides/run in conjunction with appropriate software allow automated counting of foci from microscope slides (Metafer slide scanning system; MetaSystems GmbH, Altlussheim, Germany). To increase the number of patients that can be analyzed in these microscopic systems, we wanted to array patient samples on microscope slides and decrease processing time. Suspension cells are classically applied onto microscope slides by cytospin centrifugation that is unable to prepare more than one sample/ slide, limiting the number of patients to be analyzed to eight in most motorized microscopic systems. The spotting technique 
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described here arrays 16 patient samples/slide, enabling the loading of 128 patient samples/run using motorized microscopic systems. In addition, the ability to stain cells in suspension prior to mounting decreases staining time and limits the unpractical handling of microscope slides during the staining procedure. The ability to use cells in suspension also allows convenient storage of large amounts of control cells in ethanol that can be added to each slide with patient samples as an internal control.
